CHRS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coherus BioSciences Inc

Watchlist Manager

Watchlist

Price: 1.21 USD -2.42%

Market Cap: $186.6m

	Coherus BioSciences Inc NASDAQ:CHRS	US
S	Salesforce Inc SWB:FOO	US
B	Baker Hughes Co SWB:68V	US
	Grab Holdings Ltd NASDAQ:GRAB	SG
	Yunnan Yuntianhua Co Ltd SSE:600096	CN
M	MERLIN Properties SOCIMI SA ELI:MRL	ES
V	Veolia Environnement SA SWB:VVD	FR
C	Celestica Inc DUS:CTW	CA
	Ferrovial SE F:8ZQ	NL
R	Rockwool A/S F:R90	DK
	Beauty Health Co F:V7A0	US
E	Epizyme Inc F:EPE	US

Profitability Summary

Coherus BioSciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

55%

Gross Margin is Increasing

50% > 69%

Negative Operating Margin

-312%

Negative 3Y Average Operating Margin

-205%

Declining Operating Margin

-126% > -312%

Negative Net Margin

-259%

Strong 3Y Average Net Margin

55%

Declining Net Margin

-145% > -259%

Negative Free Cash Flow Margin

-365%

Negative 3Y Average Free Cash Flow Margin

-133%

Declining Free Cash Flow Margin

-135% > -365%

Negative ROE

-146%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-61%

Declining ROIC

-84% > -134%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.